Eli Lilly Gains Boost from New Pill Data; U.S. Fast-Track Approval Still Uncertain, Officials Say

Eli Lilly (LLY.N) on Wednesday launched a fresh bid for regulatory approval of its experimental weight-loss pill, supported by new clinical trial data. However, company executives...